-
Archie Lovatt
SGS
Episode 42
The understated, elite vaccine scientist
Read moreIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Archie Lovatt Life Sciences Biosafety Scientific Director at SGS. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Archie, covering: Being motivated by saving lives and seeing your contribution make a real …
-
Jeff Dill
Vynamic
Episode 41
Creating a healthy culture
Read moreIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeff Dill, CEO at Vynamic. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jeff, covering:· How to create, document, grow and internationally scale an incredible business culture. The shift towards greater industry collaboration as …
-
Raman Sehgal
ramarketing & PR Limited
Episode 40
40 at 40
Read moreIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Raman Sehgal Founder & Global President of ramarketing & usual host of the Molecule to Market podcast. Raman has 20+ years of marketing and life science industry experience. Starting his career and setting up his business in the UK, Raman …
-
Gerry Cox
Velesco Pharmaceutical Services.
Episode 39
From Pfizer to CDMO start-up
Read moreIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gerry, covering: The transition from two decades in Big Pharma to the …
-
Megan Greth and Tadgh Prendeville
ARx LLC
Episode 38
Expanding drug dosage possibilities…
Read moreIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Megan Greth, Director of Marketing & Business Development and Tadgh Prendeville, General Manager at ARx LLC. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Megan and Tadgh, covering: ● …
-
Jarlath Keating
ABL inc.
Episode 37
From Teesside Uni to global leader
Read moreIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jarlath Keating President & CEO at ABL Inc. Jarlath has over 25 years of global life science industry experience. Starting his career in the UK in the early 90’s before transitioning to the US in …
-
Richard Johnson
Upperton Pharma Solutions
Episode 36
The accidental CDMO
Read moreIn this episode of Molecule to Market, your host Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with guest Richard Johnson, Founding Director of Upperton Pharma Solutions. With more than 25 years of experience in the industry, Richard is a founding director of two successful pharmaceutical companies. He has authored 30 scientific publications and …
-
Robert Lee Ph.D.
Lubrizol Life Science Health (LLS)
Episode 35
The passionate problem solver
Read moreIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Robert Lee Ph.D., President at the CDMO Division of Lubrizol Life Science Health (LLS). Rob has over 30 years’ experience in the pharmaceutical R&D space and his areas of expertise include drug delivery, formulation development, …
-
Alok Tayi
Egnyte
Episode 34
The entrepreneurial scientist
Read moreIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Alok Tayi, Vice President of Life Sciences at Egnyte and the founder of the Biotech 2050 podcast. Alok has a very impressive academic and entrepreneurial background in life sciences, before running the fast-growing life science …
-
Ian Altman
Best-Selling Sales Author
Episode 33
The sales guru
Read moreIn this episode of Molecule to Market, we do things a little differently with an experimental episode. You’ll go inside the outsourcing space of the global drug development sector with the best-selling sales author, Ian Altman. Ian started, sold, and grew his prior companies from zero to over one billion dollars in value. He’s a …